Geron Corp. buy Slaandjivaa
Start price
16.01.18
/
50%
€1.94
Target price
01.03.18
€2.26
Performance (%)
8.12%
End price
01.03.18
€2.10
Summary
This prediction ended on 01.03.18 with a price of €2.10. The BUY prediction by Slaandjivaa finished with a performance of 8.12%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Geron Corp. | 0.038% | 0.038% | 12.074% | -44.407% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by Slaandjivaa for this prediction
In the thread Geron Corp. diskutieren
Gerne Geron
https://seekingalpha.com/article/4137225-toxicity-gerons-imetelstat-may-lead-accelerated-fda-approval
(Vom Mitglied beendet)


